Variant report

Variant	nsv1017469
Chromosome Location	chr5:17373383-17416643
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:738)
CpG islands
(count:366)
Chromatin interactive
region (count:21)
LncRNA
region (count:24)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:738 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:17398657-17398856	K562	blood:	n/a	n/a
2	ARID3A	chr5:17400080-17400209	K562	blood:	n/a	n/a
3	ATF1	chr5:17413435-17413764	K562	blood:	n/a	n/a
4	ATF1	chr5:17398236-17399036	K562	blood:	n/a	n/a
5	ATF1	chr5:17400709-17401396	K562	blood:	n/a	n/a
6	ATF1	chr5:17400131-17400411	K562	blood:	n/a	n/a
7	ATF1	chr5:17415654-17415786	K562	blood:	n/a	n/a
8	ATF2	chr5:17401891-17402229	H1-hESC	embryonic stem cell:	n/a	n/a
9	ATF3	chr5:17374208-17374748	A549	lung:	n/a	chr5:17374468-17374481 chr5:17374469-17374480 chr5:17374467-17374478 chr5:17374471-17374478 chr5:17374471-17374481 chr5:17374467-17374482 chr5:17374468-17374479 chr5:17374468-17374481 chr5:17374470-17374478 chr5:17374468-17374478 chr5:17374471-17374481
10	ATF3	chr5:17374151-17374643	A549	lung:	n/a	chr5:17374468-17374481 chr5:17374469-17374480 chr5:17374467-17374478 chr5:17374471-17374478 chr5:17374471-17374481 chr5:17374467-17374482 chr5:17374468-17374479 chr5:17374468-17374481 chr5:17374470-17374478 chr5:17374468-17374478 chr5:17374471-17374481
11	ATF3	chr5:17375481-17375880	A549	lung:	n/a	n/a
12	BACH1	chr5:17415528-17415532	H1-hESC	embryonic stem cell:	n/a	n/a
13	BACH1	chr5:17400938-17402146	H1-hESC	embryonic stem cell:	n/a	n/a
14	BACH1	chr5:17375539-17375965	H1-hESC	embryonic stem cell:	n/a	n/a
15	BACH1	chr5:17413521-17413685	K562	blood:	n/a	chr5:17413586-17413600
16	BATF	chr5:17413423-17413703	GM12878	blood:	n/a	chr5:17413589-17413600
17	BCL3	chr5:17375394-17375931	A549	lung:	n/a	n/a
18	BCL3	chr5:17374148-17374782	A549	lung:	n/a	n/a
19	BCL3	chr5:17398488-17398790	GM12878	blood:	n/a	n/a
20	BCL3	chr5:17375239-17375886	A549	lung:	n/a	n/a
21	BCL3	chr5:17401782-17402305	A549	lung:	n/a	chr5:17402272-17402281
22	BCL3	chr5:17373943-17375100	A549	lung:	n/a	n/a
23	BCL3	chr5:17378259-17378998	A549	lung:	n/a	chr5:17378346-17378355
24	BHLHE40	chr5:17413400-17413989	K562	blood:	n/a	n/a
25	BHLHE40	chr5:17402043-17402129	A549	lung:	n/a	n/a
26	BHLHE40	chr5:17413480-17413606	GM12878	blood:	n/a	n/a
27	BHLHE40	chr5:17400134-17400222	K562	blood:	n/a	n/a
28	BHLHE40	chr5:17398695-17398915	K562	blood:	n/a	n/a
29	BRCA1	chr5:17406577-17407006	Hela-S3	cervix:	n/a	n/a
30	BRCA1	chr5:17377970-17379954	Hela-S3	cervix:	n/a	n/a
31	BRCA1	chr5:17375584-17375909	Hela-S3	cervix:	n/a	n/a
32	CCNT2	chr5:17400915-17401502	K562	blood:	n/a	n/a
33	CCNT2	chr5:17413432-17413642	K562	blood:	n/a	n/a
34	CCNT2	chr5:17400128-17400357	K562	blood:	n/a	n/a
35	CEBPB	chr5:17374276-17374754	A549	lung:	n/a	n/a
36	CEBPB	chr5:17401207-17401412	IMR90	lung:	n/a	chr5:17401288-17401299
37	CEBPB	chr5:17411605-17411851	A549	lung:	n/a	chr5:17411694-17411707 chr5:17411696-17411707 chr5:17411696-17411707 chr5:17411694-17411707
38	CEBPB	chr5:17394873-17395134	HepG2	liver:	n/a	chr5:17395016-17395027
39	CEBPB	chr5:17398657-17398694	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr5:17382552-17382599	K562	blood:	n/a	n/a
41	CEBPB	chr5:17394857-17395075	IMR90	lung:	n/a	chr5:17395016-17395027
42	CEBPB	chr5:17378354-17378887	A549	lung:	n/a	n/a
43	CEBPB	chr5:17401143-17401427	A549	lung:	n/a	chr5:17401288-17401299
44	CEBPB	chr5:17378426-17378822	MCF-7	breast:	n/a	n/a
45	CEBPB	chr5:17411531-17411914	IMR90	lung:	n/a	chr5:17411694-17411707 chr5:17411696-17411707 chr5:17411696-17411707 chr5:17411694-17411707
46	CEBPB	chr5:17375550-17375848	A549	lung:	n/a	n/a
47	CEBPB	chr5:17406732-17406967	IMR90	lung:	n/a	n/a
48	CEBPB	chr5:17379329-17379640	Hela-S3	cervix:	n/a	n/a
49	CEBPB	chr5:17401122-17401458	K562	blood:	n/a	chr5:17401288-17401299
50	CEBPB	chr5:17406735-17407070	A549	lung:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:17381798-17381848	BE2_C	brain:	n/a
2	chr5:17395952-17396002	Hepatocyte	liver:	n/a
3	chr5:17414184-17414234	HCT-116	colon:	n/a
4	chr5:17395952-17396002	SK-N-MC	brain:	n/a
5	chr5:17400323-17400373	PFSK-1	brain:	n/a
6	chr5:17381798-17381848	BJ	skin:	n/a
7	chr5:17400323-17400373	AoSMC	blood vessel:	n/a
8	chr5:17395952-17396002	HRE	kidney:	n/a
9	chr5:17395952-17396002	PANC-1	pancreas:	n/a
10	chr5:17414184-17414234	BE2_C	brain:	n/a
11	chr5:17414184-17414234	HMEC	breast:	n/a
12	chr5:17381798-17381848	Caco-2	colon:	n/a
13	chr5:17401890-17401940	CMK	blood:	n/a
14	chr5:17374655-17374705	GM12878	blood:	n/a
15	chr5:17400323-17400373	ECC-1	luminal epithelium:	n/a
16	chr5:17381798-17381848	K562	blood:	n/a
17	chr5:17395952-17396002	A549	lung:	n/a
18	chr5:17400323-17400373	AG04449	skin:	fetal
19	chr5:17400323-17400373	ProgFib	skin:	n/a
20	chr5:17401890-17401940	HCF	heart:	n/a
21	chr5:17395952-17396002	ECC-1	luminal epithelium:	n/a
22	chr5:17395952-17396002	LNCaP	prostate:	n/a
23	chr5:17401890-17401940	GM12878	blood:	n/a
24	chr5:17400323-17400373	GM12892	blood:	n/a
25	chr5:17414184-17414234	MCF-7	breast:	n/a
26	chr5:17374655-17374705	HL-60	blood:	n/a
27	chr5:17401890-17401940	ECC-1	luminal epithelium:	n/a
28	chr5:17414184-17414234	Hepatocyte	liver:	n/a
29	chr5:17374655-17374705	HCT-116	colon:	n/a
30	chr5:17395952-17396002	GM19239	blood:	n/a
31	chr5:17414184-17414234	HEEpiC	esophagus:	n/a
32	chr5:17395952-17396002	NHDF-neo	bronchial:	n/a
33	chr5:17374655-17374705	U87	brain:	n/a
34	chr5:17374655-17374705	Caco-2	colon:	n/a
35	chr5:17381798-17381848	HAEpiC	amniotic membrane:	n/a
36	chr5:17400323-17400373	GM06990	blood:	n/a
37	chr5:17400323-17400373	SK-N-MC	brain:	n/a
38	chr5:17400323-17400373	PrEC	prostate:	n/a
39	chr5:17395952-17396002	HL-60	blood:	n/a
40	chr5:17414184-17414234	ProgFib	skin:	n/a
41	chr5:17374655-17374705	HIPEpiC	eye:	n/a
42	chr5:17400323-17400373	HepG2	liver:	n/a
43	chr5:17381798-17381848	HL-60	blood:	n/a
44	chr5:17414184-17414234	GM12892	blood:	n/a
45	chr5:17395952-17396002	K562	blood:	n/a
46	chr5:17381798-17381848	GM12891	blood:	n/a
47	chr5:17400323-17400373	AG10803	skin:	n/a
48	chr5:17400323-17400373	K562	blood:	n/a
49	chr5:17395952-17396002	PFSK-1	brain:	n/a
50	chr5:17381798-17381848	HEK293	kidney:	embryo

(count:21 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:17379053..17381282-chr5:17384689..17387126,2	MCF-7	breast:
2	chr5:17365516..17367373-chr5:17399549..17401386,2	K562	blood:
3	chr5:17379053..17381282-chr5:17384689..17387126,2	MCF-7	breast:
4	chr5:17401084..17403430-chr5:17409103..17412028,2	K562	blood:
5	chr5:17391442..17394133-chr5:17400985..17402513,2	MCF-7	breast:
6	chr5:17374822..17377145-chr5:17377368..17380212,2	K562	blood:
7	chr5:17380001..17380969-chr9:21802240..21803053,2	Hela-S3	cervix:
8	chr5:17216329..17216875-chr5:17413138..17413983,2	MCF-7	breast:
9	chr5:17393977..17396441-chr5:17404895..17406641,2	MCF-7	breast:
10	chr5:17413771..17415306-chr5:17416901..17419149,2	MCF-7	breast:
11	chr5:17401084..17403430-chr5:17409103..17412028,2	K562	blood:
12	chr5:17215642..17218111-chr5:17382482..17385091,2	MCF-7	breast:
13	chr5:17374463..17376322-chr5:17377368..17380030,2	K562	blood:
14	chr5:17399274..17401360-chr5:17404322..17406946,2	MCF-7	breast:
15	chr5:17391442..17394133-chr5:17400985..17402513,2	MCF-7	breast:
16	chr5:17215908..17217514-chr5:17379687..17381481,2	MCF-7	breast:
17	chr5:17393977..17396441-chr5:17404895..17406641,2	MCF-7	breast:
18	chr5:17215792..17218205-chr5:17402099..17403683,2	MCF-7	breast:
19	chr5:17216760..17218355-chr5:17375692..17378391,2	MCF-7	breast:
20	chr5:17216804..17218598-chr5:17393185..17395511,2	MCF-7	breast:
21	chr5:17399274..17401360-chr5:17404322..17406946,2	MCF-7	breast:

(count:24 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BASP1-3	chr5:17404667-17404840	XLOC_004308
2	lnc-MYO10-3	chr5:17379016-17380619	XLOC_004746
3	lnc-BASP1-3	chr5:17404128-17404197	XLOC_004308
4	lnc-MYO10-3	chr5:17387311-17387419	ENSG00000250822
5	lnc-BASP1-3	chr5:17404534-17404840	NONHSAT100631
6	lnc-MYO10-3	chr5:17378843-17379311	XLOC_004746
7	lnc-BASP1-3	chr5:17412001-17412207	XLOC_004308
8	lnc-BASP1-3	chr5:17404039-17404474	NONHSAT100631
9	lnc-MYO10-3	chr5:17384952-17385549	XLOC_004746
10	lnc-BASP1-3	chr5:17404535-17404838	XLOC_004308
11	lnc-MYO10-3	chr5:17378026-17378606	XLOC_004746
12	lnc-BASP1-3	chr5:17404255-17404460	XLOC_004308
13	lnc-MYO10-2	chr5:17375567-17375686	XLOC_004745
14	lnc-MYO10-3	chr5:17384952-17385549	ENSG00000250822
15	lnc-MYO10-3	chr5:17379015-17380619	ENSG00000250822
16	lnc-BASP1-3	chr5:17404535-17404838	XLOC_004308
17	lnc-BASP1-3	chr5:17404005-17404178	XLOC_004308
18	lnc-BASP1-3	chr5:17404098-17404197	NONHSAT100634
19	lnc-MYO10-3	chr5:17387311-17387419	XLOC_004746
20	lnc-BASP1-3	chr5:17404213-17404838	XLOC_004308
21	lnc-BASP1-3	chr5:17404535-17404701	XLOC_004308
22	lnc-BASP1-3	chr5:17404040-17404197	XLOC_004308
23	lnc-BASP1-3	chr5:17404217-17404429	XLOC_004308
24	lnc-BASP1-3	chr5:17412000-17412207	NONHSAT100631

No data

Variant related genes	Relation type
ENSG00000248455	TF binding region
ENSG00000249199	TF binding region
ENSG00000250822	TF binding region
ENSG00000248455	CpG island
ENSG00000249199	CpG island
ENSG00000250822	CpG island
ENSG00000249199	chromatin interactions
ENSG00000264545	chromatin interactions
ENSG00000215196	chromatin interactions
ENSG00000176788	chromatin interactions
ENSG00000099810	chromatin interactions
GTF2H1	miRNA target sites
KRAS	miRNA target sites
MMP24	miRNA target sites
GXYLT1	miRNA target sites
RNF41	miRNA target sites
RAD51	miRNA target sites
MMP2	miRNA target sites

Extended variants
information (count: 1472 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:1472 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs552938059	chr5:17373474-17373475	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs571251966	chr5:17373522-17373523	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs150400527	chr5:17373575-17373576	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs563547413	chr5:17373589-17373590	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs538317244	chr5:17373606-17373607	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs376928579	chr5:17373697-17373698	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs35270186	chr5:17373702-17373703	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs550646315	chr5:17373709-17373710	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs138674247	chr5:17373750-17373751	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs148897350	chr5:17373778-17373779	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs145490729	chr5:17373780-17373781	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs566688343	chr5:17373830-17373831	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs368181417	chr5:17373832-17373833	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs531728969	chr5:17373858-17373859	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs538542420	chr5:17373975-17373976	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs137990124	chr5:17373995-17373996	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs575231199	chr5:17373997-17373998	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs142481880	chr5:17374009-17374010	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs6868074	chr5:17374010-17374011	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs298540	chr5:17374079-17374080	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs540747538	chr5:17374107-17374108	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs376534656	chr5:17374112-17374113	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs560502801	chr5:17374152-17374153	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs532780575	chr5:17374189-17374190	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs553574745	chr5:17374277-17374278	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs145955895	chr5:17374305-17374306	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs563175327	chr5:17374366-17374367	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs114056754	chr5:17374461-17374462	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs80265929	chr5:17374475-17374476	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs369775663	chr5:17374641-17374642	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs565492032	chr5:17374655-17374656	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs6555000	chr5:17374669-17374670	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs376139378	chr5:17374699-17374700	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs74404237	chr5:17374782-17374783	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs529733356	chr5:17374804-17374805	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs159606	chr5:17374898-17374899	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs576005112	chr5:17374919-17374920	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs376775363	chr5:17374976-17374977	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs538493872	chr5:17375001-17375002	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs558383982	chr5:17375042-17375043	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs192125105	chr5:17375114-17375115	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs2859621	chr5:17375123-17375124	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
43	rs553045992	chr5:17375130-17375131	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs7713992	chr5:17375144-17375145	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs554644834	chr5:17375153-17375154	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs574809419	chr5:17375421-17375422	Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs534024697	chr5:17375472-17375473	Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs554286665	chr5:17375495-17375496	Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs577317223	chr5:17375549-17375550	Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs182883779	chr5:17375599-17375600	Active TSS Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Multiple myeloma	17550852	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Esophageal adenocarcinoma	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Intellectual disability	22102821	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	21364760	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Myoepithelioma	18604193	CNVD
Lung cancer	16740712	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Melanoma	22183965	CNVD
Renal cell carcinoma	18194544	CNVD
Prostate cancer	21965145	CNVD
Ovarian cancer	20844748	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD

Chromatin state (count:674 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:17362200-17375200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr5:17366000-17374600	Weak transcription	Fetal Brain Female	brain
3	chr5:17366400-17373600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
4	chr5:17367200-17373600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr5:17368000-17373400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
6	chr5:17368400-17373400	Weak transcription	HUES48 Cell Line	embryonic stem cell
7	chr5:17368400-17373400	Weak transcription	HUES64 Cell Line	embryonic stem cell
8	chr5:17368400-17373600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
9	chr5:17368400-17373800	Weak transcription	H1 Cell Line	embryonic stem cell
10	chr5:17368400-17373800	Weak transcription	H9 Cell Line	embryonic stem cell
11	chr5:17368400-17373800	Weak transcription	HUES6 Cell Line	embryonic stem cell
12	chr5:17368400-17374200	Weak transcription	Hela-S3	cervix
13	chr5:17368400-17375200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
14	chr5:17368600-17373600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
15	chr5:17370800-17373600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
16	chr5:17371000-17375000	Weak transcription	Placenta	Placenta
17	chr5:17371200-17373400	Weak transcription	A549	lung
18	chr5:17371200-17378200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
19	chr5:17371400-17373400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
20	chr5:17371400-17373600	Weak transcription	HMEC	breast
21	chr5:17371400-17375000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
22	chr5:17371400-17378200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
23	chr5:17372200-17373600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
24	chr5:17373400-17373600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr5:17373400-17375400	Enhancers	HUES48 Cell Line	embryonic stem cell
26	chr5:17373400-17375400	Flanking Active TSS	A549	lung
27	chr5:17373400-17375600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr5:17373400-17375800	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr5:17373400-17375800	Enhancers	iPS-15b Cell Line	embryonic stem cell
30	chr5:17373600-17374000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
31	chr5:17373600-17374000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
32	chr5:17373600-17374000	Enhancers	GM12878-XiMat	blood
33	chr5:17373600-17374000	Enhancers	HMEC	breast
34	chr5:17373600-17374400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
35	chr5:17373600-17374400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr5:17373600-17374400	Enhancers	Primary monocytes fromperipheralblood	blood
37	chr5:17373600-17374400	Enhancers	Monocytes-CD14+_RO01746	blood
38	chr5:17373600-17374600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
39	chr5:17373600-17374600	Enhancers	Primary B cells from peripheral blood	blood
40	chr5:17373600-17375000	Enhancers	ES-I3 Cell Line	embryonic stem cell
41	chr5:17373600-17375200	Enhancers	iPS-20b Cell Line	embryonic stem cell
42	chr5:17373600-17375400	Enhancers	iPS-18 Cell Line	embryonic stem cell
43	chr5:17373600-17375400	Enhancers	NH-A	brain
44	chr5:17373600-17375800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr5:17373800-17374200	Enhancers	H1 Cell Line	embryonic stem cell
46	chr5:17373800-17374200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
47	chr5:17373800-17374400	Enhancers	H9 Cell Line	embryonic stem cell
48	chr5:17373800-17375800	Enhancers	HUES6 Cell Line	embryonic stem cell
49	chr5:17374000-17375000	Weak transcription	HMEC	breast
50	chr5:17374000-17375200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links